[Latest] Global Pharmaceutical Contract Packaging Market Size/Share Worth USD 34.80 Billion by 2034 at a 7.34% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

Austin, TX, USA, May 20, 2025 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled “Pharmaceutical Contract Packaging Market Size, Trends and Insights By Type (Primary Packaging, Secondary Packaging, Tertiary Packaging), By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034“ in its research database.

“According to the latest research study, the demand of the global Pharmaceutical Contract Packaging Market size & share was valued at approximately USD 17.35 Billion in 2024 and is expected to reach USD 18.40 Billion in 2025 and is expected to reach a value of around USD 34.80 Billion by 2034, at a compound annual growth rate (CAGR) of about 7.34% during the forecast period 2025 to 2034.”

Click Here to Access a Free Sample Report of the Global Pharmaceutical Contract Packaging Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=69819

Pharmaceutical Contract Packaging Market Overview

As per the industry experts at CMI, the pharmaceutical contract packaging industry is highly driven by increased demand for outsourced packaging processes by pharmaceutical businesses seeking to contain operating costs and enhance efficiency. As drug development increases and advanced biologics enter the pipeline, pharmaceutical businesses increasingly seek specialized contract packaging solutions to ensure regulatory compliance and speedy market delivery.

In addition, growing emphasis on tamper-evident, anti-counterfeit, and environmentally friendly packaging forms triggered by strict government regulations and safety awareness among consumers further propels the market forward. Greater traceability and serialization demands across North America and Europe also contribute to the necessity of third-party reliable packaging services.

The integration of digital solutions and automation with contract packaging operations continues to increase service capacity, efficiency, and customer satisfaction across this expanding global market.

Pharmaceutical Contract Packaging Market Growth Factors and Dynamics

• Rising Complexity of Pharmaceutical Product Portfolios: The pharma industry is undergoing change with biologics, personalized medicine, and combination product development. These products commonly require specialized packaging to address stability, sterility, and patient compliance needs. CPOs provide expertise and facilities that can manage the complexity so the pharma organization can concentrate on core business. For example, as per the U.S. Food and Drug Administration (FDA), biologic license applications have registered a consistent growth, with more than 60 approvals in 2023 alone, reflecting an escalating demand for customized packaging solutions. Increasing demand for customized packaging solutions is thus driving growth in the contract packaging market.

• Stringent Regulatory Requirements and Serialization Mandates: Global regulatory agencies have imposed strict regulations to guarantee the safety and traceability of pharmaceutical products. Serialization requirements, which necessitate unique identification codes on packs of drugs, have become a central issue in the fight against counterfeit medicines. The application of these requirements demands sophisticated packaging technologies and processes, leading pharmaceutical companies to outsource to CPOs with such capabilities. For example, the Falsified Medicines Directive (FMD) of the European Union requires serialization of all prescription drugs, scanning in excess of 4 billion packages a year, hence enhancing dependence on specialist contract packaging services. This phenomenon enormously promotes the contract packaging industry because compliance issues become an important business driver.

Request a Customized Copy of the Pharmaceutical Contract Packaging Market Report @ https://www.custommarketinsights.com/request-for-customization/?reportid=69819

• Increasing Complexity of Pharmaceutical Product Portfolios: The pharmaceutical industry is confronted with diversification of product portfolios in the shape of personalized drugs, combination treatments, and multiple dosage forms. This sophistication requires This sophistication requires flexibility and versatility in packaging to meet the specific needs of individual products. The National Institutes of Health (NIH) states that personal medicine programs have been funded to the tune of more than $1 billion since 2020, reflecting increasingly complex and individualized pharmaceutical products. Contract packagers provide the flexibility and technical expertise required to handle such varied demands in an efficient manner and thus prove to be beneficial partners for drug companies seeking to simplify operations and concentrate on core functions.

• Rising Demand for Sustainable and Eco-Friendly Packaging: Sustainability has become a key driver of the pharmaceutical contract packaging industry, driven by mounting regulatory pressures, environmental issues, and changing consumer behavior. Governments and international institutions are promoting plastic waste, carbon footprint, and non-recyclable material reductions in all industries, including pharmaceuticals. In response, contract packaging companies (CPOs) are investing in sustainable materials like biodegradable plastics, lightweight glass, and recyclable aluminium parts. Solutions such as recyclable blister packs, solvent-free adhesives, and mono-material packaging are becoming more popular. Aside from environmental concerns, sustainable packaging solutions can lower transportation expenses through lighter wexpenses and maximize shelf-space efficiency. Pharmaceutical companies are also integrating sustainability into their ESG (Environmental, Social, Governance) strategies, which enhances brand equity and meets investor expectations. Customers are increasinCustomers are increasingly favoring CPOs who can provide verified eco-friendly packaging options and closed-loop recycling systems.inability is no longer optional it’s a competitive differentiator that influences buyer decisions in the contract packaging market.

Report Scope